Amyris Inc. [NASDAQ: AMRS] stock went on an upward path that rose over 1.70% on Thursday, amounting to a one-week price decrease of less than -2.87%. The company report on April 21, 2021 that Amyris To Host First Quarter 2021 Financial Results Conference Call On May 6.
Amyris, Inc., (Nasdaq: AMRS) a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced that it will issue its financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021 prior to the opening of the financial markets. The company will hold a conference call and live audio webcast at 6:00 am Pacific Time (9:00 a.m. Eastern Time).
On the call, John Melo, President and Chief Executive Officer, Han Kieftenbeld, Chief Financial Officer, and Eduardo Alvarez, Chief Operating Officer, will discuss Amyris’s financial results and provide an update on the company’s business.
Over the last 12 months, AMRS stock rose by 470.79%. The average equity rating for AMRS stock is currently 1.60, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $4.34 billion, with 246.82 million shares outstanding and 154.20 million shares in the current float. Compared to the average trading volume of 4.94M shares, AMRS stock reached a trading volume of 5000259 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Amyris Inc. [AMRS]:
H.C. Wainwright have made an estimate for Amyris Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 03, 2021. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on February 26, 2021, representing the official price target for Amyris Inc. stock. Previously, the target price had yet another raise to $9, while Cowen analysts kept a Outperform rating on AMRS stock.
The Average True Range (ATR) for Amyris Inc. is set at 1.53, with the Price to Sales ratio for AMRS stock in the period of the last 12 months amounting to 25.07.
AMRS Stock Performance Analysis:
Amyris Inc. [AMRS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.87. With this latest performance, AMRS shares dropped by -27.98% in over the last four-week period, additionally plugging by 434.74% over the last 6 months – not to mention a rise of 470.79% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRS stock in for the last two-week period is set at 43.20, with the RSI for the last a single of trading hit 40.53, and the three-weeks RSI is set at 46.32 for Amyris Inc. [AMRS]. The present Moving Average for the last 50 days of trading for this stock 17.25, while it was recorded at 14.83 for the last single week of trading, and 7.74 for the last 200 days.
Insight into Amyris Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Amyris Inc. [AMRS] shares currently have an operating margin of -71.29 and a Gross Margin at +45.83. Amyris Inc.’s Net Margin is presently recorded at -182.03.
Additionally, AMRS Total Debt to Total Capital is recorded at 255.68, with Total Debt to Total Assets ending up at 126.65.
Reflecting on the efficiency of the workforce at the company, Amyris Inc. [AMRS] managed to generate an average of -$529,681 per employee. Receivables Turnover for the company is 4.32 with a Total Asset Turnover recorded at a value of 0.90.Amyris Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.90.
AMRS Stock EPS
With the latest financial reports released by the company, Amyris Inc. posted -0.56/share EPS, while the average EPS was predicted by analysts to be reported at -0.19/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -194.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amyris Inc. go to 30.00%.
Amyris Inc. [AMRS] Insider Position Details
There are presently around $1,513 million, or 37.00% of AMRS stock, in the hands of institutional investors. The top three institutional holders of AMRS stocks are: FMR LLC with ownership of 18,442,566, which is approximately 12.211% of the company’s market cap and around 30.25% of the total institutional ownership; FARALLON CAPITAL MANAGEMENT LLC, holding 17,500,000 shares of the stock with an approximate value of $266.7 million in AMRS stocks shares; and VIVO CAPITAL, LLC, currently with $200.59 million in AMRS stock with ownership of nearly 0.022% of the company’s market capitalization.
Positions in Amyris Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 97 institutional holders increased their position in Amyris Inc. [NASDAQ:AMRS] by around 22,089,863 shares. Additionally, 35 investors decreased positions by around 26,590,457 shares, while 18 investors held positions by with 50,626,990 shares. The mentioned changes placed institutional holdings at 99,307,310 shares, according to the latest SEC report filing. AMRS stock had 43 new institutional investments in for a total of 7,286,871 shares, while 19 institutional investors sold positions of 18,811,923 shares during the same period.